Philadelphia Pharmaceuticals Company (ASE:PHIL)

ASE:PHIL Ratios and Metrics

Market cap in millions JOD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 6, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	12	11	11	10	10	11
Market Cap Growth	7.64%	4.90%	2.88%	1.46%	-4.20%	-8.33%
Enterprise Value	12	12	11	11	11	11
Last Close Price	1.55	1.43	1.30	1.21	1.14	1.19
PE Ratio	12.73	13.69	13.29	14.87	25.05	75.68
PS Ratio	1.28	1.28	1.28	1.24	1.56	1.40
PB Ratio	0.88	0.86	0.84	0.84	0.85	0.94
P/TBV Ratio	0.88	0.86	0.84	0.84	1.06	0.94
P/FCF Ratio	5.77	7.37	10.37	5.37	3.49	6.86
P/OCF Ratio	8.58	6.54	9.75	4.95	3.27	6.30
EV/Sales Ratio	1.32	1.36	1.36	1.28	1.66	1.47
EV/EBITDA Ratio	8.24	7.13	6.94	8.83	12.45	15.90
EV/EBIT Ratio	8.36	8.53	8.45	9.79	15.22	26.30
EV/FCF Ratio	5.95	7.80	11.07	5.54	3.72	7.19
Debt / Equity Ratio	0.15	0.15	0.12	0.15	0.12	0.14
Debt / EBITDA Ratio	1.35	1.19	0.90	1.50	1.65	2.33
Debt / FCF Ratio	0.98	1.30	1.44	0.94	0.49	1.05
Net Debt / Equity Ratio	0.03	0.03	0.01	0.03	-0.02	0.00
Net Debt / EBITDA Ratio	0.25	0.20	0.06	0.27	-0.24	0.06
Net Debt / FCF Ratio	0.18	0.22	0.09	0.17	-0.07	0.03
Asset Turnover	0.55	0.54	0.53	0.55	0.44	0.49
Inventory Turnover	2.52	2.45	2.66	2.93	1.83	2.08
Quick Ratio	2.76	2.88	2.39	2.27	2.87	2.89
Current Ratio	3.52	3.67	3.08	2.73	3.48	3.54
Return on Equity (ROE)	7.03%	6.37%	6.42%	5.72%	3.48%	1.23%
Return on Assets (ROA)	5.37%	5.34%	5.32%	4.44%	2.99%	1.72%
Return on Invested Capital (ROIC)	8.24%	8.42%	8.38%	7.22%	5.10%	3.01%
Return on Capital Employed (ROCE)	10.30%	10.10%	10.60%	8.90%	5.90%	3.70%
Earnings Yield	7.86%	7.30%	7.53%	6.73%	3.99%	1.32%
FCF Yield	17.32%	13.57%	9.64%	18.62%	28.63%	14.57%
Dividend Yield	4.52%	4.89%	5.38%	4.96%	5.26%	-
Payout Ratio	57.49%	63.91%	55.75%	64.18%	-	264.62%
Total Shareholder Return	4.52%	4.89%	5.38%	4.96%	5.26%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.